Diabetic macular oedema (DMO) is the major cause of visual impairment in people with diabetes. Optical coherence tomography (OCT) is now the most widely used modality to …
Diabetic macular edema (DME) is the most common cause of visual impairment among patients with diabetes mellitus. Anti-vascular endothelial growth factors (Anti-VEGFs) are …
Diabetic macular oedema (DMO) is one of the leading causes of vision loss associated with diabetic retinopathy (DR). New insights in managing this condition have changed the …
Background Exudative age-related macular degeneration (AMD), one of the leading causes of blindness, requires expensive drugs such as anti–vascular endothelial growth factor …
Purpose Various treatment regimens are currently practiced in the treatment of CI-DMO (centre-involving diabetic macular oedema). In recent years, there has been a growing body …
H Mistry, M Maredza, C Campbell, N Lois - BMJ open, 2023 - bmjopen.bmj.com
Objectives To estimate the economic costs, health-related quality-of-life outcomes and cost- effectiveness of subthreshold micropulse laser (SML) versus standard laser (SL) for the …
H Huang, SX Qian - Frontiers in Medicine, 2023 - frontiersin.org
Lichen myxedematosus (LM) is an idiopathic cutaneous mucinosis disorder, and monoclonal gammopathy of undetermined significance (MGUS) is a preneoplastic plasma …
S Song, CA Lemire, B Seto… - European Journal of …, 2023 - journals.sagepub.com
Purpose To study the long-term anatomic and physiologic effects of nocturnal normobaric hyperoxia (NNBH) in a patient with treatment-resistant diabetic macular edema (DME) …